SPONSORED CONTENT
CLEVELAND, Ohio – Brennan Manna Diamond is proud to spotlight client Kinomatic, an orthopedic technology company focused on improving the surgical journey for patients undergoing joint replacement procedures.
In September 2026, Kinomatic celebrated a significant milestone with the relocation of its corporate headquarters from Arroyo Grande, California, to Cleveland, Ohio. The move places the company in the heart of Cleveland’s Health-Tech Corridor and positions it alongside one of the nation’s leading healthcare and medical innovation ecosystems.
Founded in 2021, Kinomatic combines patient-specific surgical planning, advanced technologies, and recovery support to help improve outcomes for hip and knee replacement patients. Since its founding, the company has expanded from a single surgeon partner in California to working with orthopedic surgeons and groups across more than 15 states.
The relocation is not only a win for Kinomatic, but for Northeast Ohio as well. As BMD CEO Jack Diamond noted:
“We are incredibly proud to have played a role in helping our client, Kinomatic, relocate its orthopedic medical technology company from California to Cleveland. This is exactly the kind of innovative, high-growth company we want to attract to Northeast Ohio, bringing together cutting-edge medical technology, world-class healthcare resources, and the entrepreneurial talent that exists in our region.”
To learn more about the company’s journey, growth, and vision for the future, we spoke with Founder and CEO Shaun Lea.
What inspired you to found Kinomatic?
“I was an orthopedic outsider, but I worked closely with surgeons to develop ambulatory surgery centers (ASCs). This gave me a unique perspective on what was going on in orthopedics. I saw how the patient incentives and surgeon incentives were completely
misaligned.
At the time I founded Kinomatic, I was trying to figure out how to optimize knee and hip replacements in the ASC setting. Kinomatic was my solution to optimize the entire episode of care by giving patients a choice to opt into a higher level of care.
As more cases move to the ASC and reimbursements decline, surgeons are forced to make tough decisions about what they can and cannot provide patients. I saw this as an opportunity to partner with surgeons to allow them to offer patients the best of everything.”
What have been some of Kinomatic’s most significant milestones or accomplishments since its founding?
“We just celebrated our five-year anniversary as a company. In that time, we went from seven employees to 50 – from one surgeon partner in California to working with surgeons and orthopedic groups in over 15 states, including some of the biggest names in orthopedics.
But ultimately, I think the biggest milestone is achieving industry-leading results in such a short period of time. Kinomatic patients have industry-leading ‘forgotten joint scores’ and net promoter scores.”
Five years out, what does orthopedic recovery look like if Kinomatic succeeds, and what becomes obsolete?
“In five years, I think the entire surgical process will evolve. Instead of 20+ disconnected steps, we will have seamless integrated systems that will accomplish two main things.
First, it will make everything easier for both patients and surgeons. We will remove a lot of the existing
complexity.
The second major thing that will happen is that both patients and surgeons will have access to comprehensive outcome data because our system collects data on the entire episode of care. This will help patients pick the best surgeons and help surgeons adopt the best
practices.”
What should patients, providers, and partners be watching for in the years ahead?
“Our mission is to improve patients’ quality of life. Any future innovations we roll out will align with that mission. The possibilities are endless.”
If a policymaker or hospital CEO reads this interview, what’s the one thing you’d want them to do differently tomorrow?
“I’d want them to embrace data collection and outcome transparency. Surgeons and hospitals are going to start competing based on their actual results.
AI has made data collection and analysis so much easier. The surgeons and hospitals that can show they have better outcomes will win in the long run.”
In your recent press release, Kinomatic referenced “the AI-native platform that will power the future of surgical planning.” Beyond joints, is the ambition eventually to move into other surgical specialties?
“AI is a great tool that can learn from surgeons and then streamline their workflows. We started in hip and knee replacement, but this can eventually expand to any type of surgery.”
As Kinomatic settles into its new home in Cleveland, the company continues to build on the momentum of its first five years while looking ahead to what’s next for patients, providers, and the future of surgical care.
Photo: Kinomatic
